| Literature DB >> 34273662 |
Gang Xing1, Zhengxing Zhi1, Ce Yi1, Jitian Zou2, Xuefeng Jing3, Anthony Yiu-Ho Woo2, Bin Lin1, Li Pan4, Yuyang Zhang5, Maosheng Cheng6.
Abstract
β2-Agonists that bind to plasmalemmal β2-adrenoceptors causing cAMP accumulation are widely used as bronchodilators in chronic respiratory diseases. Here, we designed and synthesized a group of 8-hydroxyquinolin-2(1H)-one analogues and studied their β2-agonistic activities with a cellular cAMP assay. Compounds B05 and C08 were identified as potent (EC50 < 20 pM) and selective β2-agonists among the compounds tested. They behaved as partial β2-agonists in non-overexpressed HEK293 cells, and possessed rapid smooth muscle relaxant actions and long duration of action in isolated guinea pig tracheal strip preparations. In summary, B05 and C08 are β2-agonists with potential applicability in chronic respiratory diseases.Entities:
Keywords: Asthma; COPD; Formoterol; Indacaterol; Olodaterol; β(2)-adrenoceptor agonist
Mesh:
Substances:
Year: 2021 PMID: 34273662 DOI: 10.1016/j.ejmech.2021.113697
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 7.088